No Borders Inc. (NBDR) Accesses Lucrative Niche as Big Players Ease Up on CBD Research and Development

February 5, 2020 12:13:18
  • The FDA has reiterated its position of not currently allowing the marketing of CBD by adding it to a food or labeling it as a dietary supplement
  • Tight FDA requirements provide an opening for startups like No Borders, Inc., which leverages blockchain supply chain technology to ensure and confirm the quality of CBD products
  • Sales of all legalized cannabis in the U.S. are projected to reach $41 billion in 2025, including $6 billion from hemp-derived CBD products.
  • CBD product sales to consumers to reach an estimated $20 billion by 2024

There is no denying that cannabidiol (CBD) is a booming market if there ever was one. However, recent developments spearheaded by the Food and Drug Administration have led analysts to expect some consolidation in the market with a consumer focus on quality, the Wall Street Journal reports.

“Aside from one prescription drug approved to treat two pediatric epilepsy disorders, (CBD) products have not been approved by the FDA, and we want to be clear that a number of questions remain regarding CBD’s safety,” Amy Abernethy, principal deputy commissioner for the…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to NBDR are available in the company’s newsroom at http://cnw.fm/NBDR

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.